Atlas Trials

Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration

Clinical trial NCT00726466 · WITHDRAWN

Trial details

NCT number
NCT00726466
Sponsor
Vitreous -Retina- Macula Consultants of New York
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Age Related Macular DegenerationAMDCNV
Start date
2008-03-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.